title: Liposomal sustained-release delivery systems for intravenous injection. III. Antitumor activity of lipophilic mitomycin C prodrug-bearing liposomes.
authors.forename: Y
authors.initials: Y
authors.lastname: Tokunaga
authors.forename: T
authors.initials: T
authors.lastname: Iwasa
authors.forename: J
authors.initials: J
authors.lastname: Fujisaki
authors.forename: S
authors.initials: S
authors.lastname: Sawai
authors.forename: A
authors.initials: A
authors.lastname: Kagayama
mesh_terms: D000818:Animals; D003692:Delayed-Action Preparations; D005260:Female; D007275:Injections, Intravenous; D007941:Leukemia P388 / Q000188:drug therapy; D008081:Liposomes; D051379:Mice; D008813:Mice, Inbred ICR; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage / Q000494:pharmacology*; D011355:Prodrugs
chemical_list: D003692:Delayed-Action Preparations; D008081:Liposomes; D008937:Mitomycins; D011355:Prodrugs; D016685:Mitomycin